tiprankstipranks
Trending News
More News >
Lantern Pharma, Inc. (LTRN)
NASDAQ:LTRN
US Market

Lantern Pharma (LTRN) Ratios

Compare
310 Followers

Lantern Pharma Ratios

LTRN's free cash flow for Q3 2025 was $―. For the 2025 fiscal year, LTRN's free cash flow was decreased by $ and operating cash flow was $―. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
3.52 <0.01 16.18 20.99 31.26
Quick Ratio
3.52 <0.01 16.18 21.20 31.34
Cash Ratio
1.24 <0.01 8.19 13.29 22.15
Solvency Ratio
-3.93 -4.70 -5.76 -4.98 -5.13
Operating Cash Flow Ratio
-3.66 >-0.01 -5.36 -4.56 -4.55
Short-Term Operating Cash Flow Coverage
-135.85 0.00 0.00 0.00 0.00
Net Current Asset Value
$ 12.30M$ 20.86M$ 40.60M$ 55.92M$ 70.34M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
0.01 0.01 <0.01 <0.01 <0.01
Debt-to-Capital Ratio
0.01 0.01 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
<0.01 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.39 1.21 1.07 1.05 1.03
Debt Service Coverage Ratio
-155.79 0.00 0.00 -69.73 0.00
Interest Coverage Ratio
0.00 0.00 0.00 -70.63 0.00
Debt to Market Cap
<0.01 0.00 0.00 0.00 0.00
Interest Debt Per Share
0.01 0.02 0.02 0.02 0.02
Net Debt to EBITDA
0.29 0.35 1.37 2.58 4.18
Profitability Margins
Gross Profit Margin
-6.56%0.00%0.00%0.00%0.00%
EBIT Margin
-20049.90%0.00%0.00%0.00%0.00%
EBITDA Margin
-20355.25%0.00%0.00%0.00%0.00%
Operating Profit Margin
-20368.70%0.00%0.00%0.00%0.00%
Pretax Profit Margin
-19123.63%0.00%0.00%0.00%0.00%
Net Profit Margin
-19123.63%0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin
-19123.63%0.00%0.00%0.00%0.00%
Net Income Per EBT
100.00%100.00%100.00%98.79%99.45%
EBT Per EBIT
93.89%93.54%89.28%98.80%98.19%
Return on Assets (ROA)
-110.50%-81.27%-36.57%-23.94%-16.63%
Return on Equity (ROE)
-99.88%-98.08%-39.02%-25.14%-17.18%
Return on Capital Employed (ROCE)
-163.55%0.52%-43.64%-25.76%-17.58%
Return on Invested Capital (ROIC)
-160.18%0.52%-43.45%-25.42%-17.45%
Return on Tangible Assets
-110.50%-81.27%-36.57%-23.94%-16.63%
Earnings Yield
-47.59%-60.53%-34.40%-21.49%-14.13%
Efficiency Ratios
Receivables Turnover
0.00 0.00 0.00 0.00 0.00
Payables Turnover
0.02 0.05 0.19 0.17 0.14
Inventory Turnover
0.00 0.00 0.00 -0.26 -0.54
Fixed Asset Turnover
0.55 0.00 0.00 0.00 0.00
Asset Turnover
<0.01 0.00 0.00 0.00 0.00
Working Capital Turnover Ratio
<0.01 0.00 0.00 0.00 0.00
Cash Conversion Cycle
-16.17K -7.93K -1.97K -3.60K -3.23K
Days of Sales Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Inventory Outstanding
0.00 0.00 0.00 -1.40K -678.14
Days of Payables Outstanding
16.17K 7.93K 1.97K 2.20K 2.55K
Operating Cycle
0.00 0.00 0.00 -1.40K -678.14
Cash Flow Ratios
Operating Cash Flow Per Share
-1.66 -1.66 -1.32 -1.18 -0.97
Free Cash Flow Per Share
-1.66 -1.66 -1.32 -1.18 -0.97
CapEx Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
-2.46K -1.41K -765.80 -458.54 -683.37
Capital Expenditure Coverage Ratio
-2.46K -1.41K -765.80 -458.54 -683.37
Operating Cash Flow Coverage Ratio
-123.19 -73.11 -61.19 -241.40 -51.68
Operating Cash Flow to Sales Ratio
-177.51 0.00 0.00 0.00 0.00
Free Cash Flow Yield
-42.62%-51.92%-30.96%-19.52%-12.19%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-2.10 -1.65 -2.91 -4.65 -7.08
Price-to-Sales (P/S) Ratio
416.69 0.00 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
3.23 1.62 1.13 1.17 1.22
Price-to-Free Cash Flow (P/FCF) Ratio
-2.35 -1.93 -3.23 -5.12 -8.20
Price-to-Operating Cash Flow Ratio
-2.26 -1.93 -3.23 -5.13 -8.22
Price-to-Earnings Growth (PEG) Ratio
-0.64 >-0.01 -0.22 -0.31 -0.37
Price-to-Fair Value
3.23 1.62 1.13 1.17 1.22
Enterprise Value Multiple
-1.76 -1.31 -1.56 -1.97 -2.91
Enterprise Value
36.03M 27.06M 24.70M 28.39M 35.70M
EV to EBITDA
-1.76 -1.31 -1.56 -1.97 -2.91
EV to Sales
357.91 0.00 0.00 0.00 0.00
EV to Free Cash Flow
-2.02 -1.52 -1.72 -2.22 -3.37
EV to Operating Cash Flow
-2.02 -1.52 -1.72 -2.22 -3.37
Tangible Book Value Per Share
1.16 1.97 3.77 5.16 6.56
Shareholders’ Equity Per Share
1.16 1.97 3.77 5.16 6.56
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 0.00 0.01 <0.01
Revenue Per Share
<0.01 0.00 0.00 0.00 0.00
Net Income Per Share
-1.78 -1.93 -1.47 -1.30 -1.13
Tax Burden
1.00 1.00 1.00 0.99 0.99
Interest Burden
0.95 1.00 1.00 0.99 1.00
Research & Development to Revenue
142.25 0.00 0.00 0.00 0.00
SG&A to Revenue
61.43 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
7.68 0.00 0.00 0.00 0.00
Income Quality
0.93 0.86 0.90 0.90 0.86
Currency in USD